{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:40:29Z","timestamp":1788151229036,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013845","name":"Pediatric Endocrine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bone.2018.05.025","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T12:57:10Z","timestamp":1527080230000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice"],"prefix":"10.1016","volume":"114","author":[{"given":"Ping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7713-0936","authenticated-orcid":false,"given":"Janet L.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2018.05.025_bb0005","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1359\/jbmr.1999.14.10.1672","article-title":"A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study","volume":"14","author":"Bailey","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.05.025_bb0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI8184","article-title":"The assembly of the adult skeleton during growth and maturation: implications for senile osteoporosis","volume":"104","author":"Riggs","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.05.025_bb0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/9467","article-title":"VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation","volume":"5","author":"Gerber","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2018.05.025_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1152\/physrev.00011.2015","article-title":"Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy","volume":"96","author":"Hartmann","year":"2016","journal-title":"Physiol. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2018.05.025_bb0025","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1542\/peds.2006-2023J","article-title":"Glucocorticoid-induced osteoporosis in children: impact of the underlying disease","volume":"119","author":"Leonard","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.bone.2018.05.025_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40610-015-0017-z","article-title":"Mesenchymal progenitor cells for the osteogenic lineage","volume":"1","author":"Ono","year":"2015","journal-title":"Curr. Mol. Biol. Rep."},{"key":"10.1016\/j.bone.2018.05.025_bb0035","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","article-title":"An overview of the regulation of bone remodelling at the cellular level","volume":"45","author":"Kular","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bone.2018.05.025_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2966-5_18","article-title":"Role of TGF-beta signaling in coupling bone remodeling","volume":"1344","author":"Crane","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bone.2018.05.025_bb0045","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2018.05.025_bb0050","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/nm.3668","article-title":"PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2018.05.025_bb0055","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-017-01509-0","article-title":"Programmed cell senescence in skeleton during late puberty","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2018.05.025_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semarthrit.2014.02.002","article-title":"A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children","volume":"44","author":"Hansen","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bone.2018.05.025_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.05.025_bb0070","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2018.05.025_bb0075","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.05.025_bb0080","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI0214538","article-title":"Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids","volume":"109","author":"Weinstein","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.05.025_bb0085","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1096\/fj.11-182519","article-title":"Glucocorticoid dose determines osteocyte cell fate","volume":"25","author":"Jia","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2018.05.025_bb0090","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bone.2009.06.030","article-title":"Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity","volume":"46","author":"Weinstein","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.05.025_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034647","article-title":"Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis","volume":"7","author":"Cui","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2018.05.025_bb0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2018.05.025_bb0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/hmg\/ddl474","article-title":"Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence","volume":"16","author":"Chen","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2018.05.025_bb0110","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2018.05.025_bb0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1203\/00006450-196705000-00005","article-title":"The relation of metabolic rate to body weight and organ size","volume":"1","author":"Holliday","year":"1967","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2018.05.025_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1474-9726.2009.00545.x","article-title":"Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice","volume":"9","author":"Weinstein","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.bone.2018.05.025_bb0125","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jss.2008.05.002","article-title":"Body surface area prediction in normal, hypermuscular, and obese mice","volume":"153","author":"Cheung","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bone.2018.05.025_bb0130","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/jbmr.1989","article-title":"Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase\/Akt and Erk pathways in association with signaling Adaptor DAP12","volume":"28","author":"Kameda","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.05.025_bb0135","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1359\/jbmr.070517","article-title":"IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone","volume":"22","author":"Wang","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.05.025_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2018.05.025_bb0145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature13145","article-title":"Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone","volume":"507","author":"Kusumbe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bone.2018.05.025_bb0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2013.12.006","article-title":"Glucocorticoids and bone: local effects and systemic implications","volume":"25","author":"Henneicke","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.05.025_bb0155","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jbmr.1567","article-title":"Demonstration of osteocytic perilacunar\/canalicular remodeling in mice during lactation","volume":"27","author":"Qing","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.05.025_bb0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","article-title":"Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions","volume":"17","author":"Bishop","year":"2014","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2018.05.025_bb0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.bone.2018.05.025_bb0170","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2018.05.025_bb0175","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/art.23454","article-title":"Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2018.05.025_bb0180","doi-asserted-by":"crossref","first-page":"315850","DOI":"10.1155\/2015\/315850","article-title":"Tetramethylpyrazine enhances vascularization and prevents osteonecrosis in steroid-treated rats","volume":"2015","author":"Jiang","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bone.2018.05.025_bb0185","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bone.2003.08.002","article-title":"The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model","volume":"33","author":"Pufe","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.05.025_bb0190","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1177\/147323001003800333","article-title":"Changes in femoral head blood supply and vascular endothelial growth factor in rabbits with steroid-induced osteonecrosis","volume":"38","author":"Wang","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bone.2018.05.025_bb0195","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/en.2017-00662","article-title":"The pathophysiological sequence of glucocorticoid-induced osteonecrosis of the femoral head in male mice","volume":"158","author":"Weinstein","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2018.05.025_bb0200","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/dvdy.23992","article-title":"Angiogenesis and intramembranous osteogenesis","volume":"242","author":"Percival","year":"2013","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bone.2018.05.025_bb0205","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI31581","article-title":"The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.05.025_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00223-016-0195-6","article-title":"A novel hybrid compound LLP2A-Ale both prevented and rescued the osteoporotic phenotype in a mouse model of glucocorticoid-induced osteoporosis","volume":"100","author":"Mohan","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2018.05.025_bb0215","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2008-1879","article-title":"Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation","volume":"94","author":"Rae","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.05.025_bb0220","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature13146","article-title":"Endothelial Notch activity promotes angiogenesis and osteogenesis in bone","volume":"507","author":"Ramasamy","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bone.2018.05.025_bb0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrrheum.2009.259","article-title":"Management of glucocorticoid-induced osteoporosis","volume":"6","author":"Compston","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2018.05.025_bb0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000381045","article-title":"Osteoporosis in children with chronic disease","volume":"28","author":"Hogler","year":"2015","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.bone.2018.05.025_bb0235","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/jc.2013-1688","article-title":"Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women","volume":"99","author":"Anderson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.05.025_bb0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00198-014-2944-6","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial","volume":"26","author":"Bone","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.05.025_bb0245","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1210\/jc.2013-2020","article-title":"Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial","volume":"98","author":"Bonnick","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.05.025_bb0250","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-013-2398-2","article-title":"Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis\u2014a double-blind, randomized, dose-finding study","volume":"25","author":"Nakamura","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.05.025_bb0255","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/er.2015-1114","article-title":"Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned","volume":"38","author":"Drake","year":"2017","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2018.05.025_bb0260","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/jcp.25389","article-title":"DC-STAMP: a key regulator in osteoclast differentiation","volume":"231","author":"Chiu","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2018.05.025_bb0265","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bone.2014.10.027","article-title":"Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis","volume":"71","author":"Kameda","year":"2015","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218302151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218302151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:40:57Z","timestamp":1762659657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218302151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":53,"alternative-id":["S8756328218302151"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.05.025","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}